Zomedica Corp.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
Alberta, Canada
Business Address
1101 TECHNOLOGY DRIVE, ANN ARBOR, MI, 48108
Mailing Address
1101 TECHNOLOGY DRIVE, ANN ARBOR, MI, 48108
Phone
(734) 369-2555
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$46.98M
Net Income
$11.70M
Total Liabilities
$240.02M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 14, 2025 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Strong 24.7% revenue growth to $7.7 million in 2024, demonstrating market acceptance.
- Successful diversification with a new $0.5 million engineering services revenue stream.
Material Events
8-K
Other
March 16, 2026
High Impact
- Achieved record revenue of $10.5 million in Q4 2025 and $32.0 million for full-year 2025, marking 20 consecutive quarters of YoY growth.
- Maintained a strong 68% gross margin for the full year, indicating healthy profitability from core product sales.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.